Showing 1,181 - 1,200 results of 44,452 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 1.23s Refine Results
  1. 1181
  2. 1182
  3. 1183

    Propensity-score matched open aortic group. by Tomi Obafemi (12328433)

    Published 2023
    “…<div><p>Introduction</p><p>Adequate peri-operative care is essential to ensuring a satisfactory outcome in cardiac surgery. In this study, we look at the impact of evidence-based protocols implemented at Stanford Hospital.…”
  4. 1184

    Pre-match CABG/Valve group. by Tomi Obafemi (12328433)

    Published 2023
    “…<div><p>Introduction</p><p>Adequate peri-operative care is essential to ensuring a satisfactory outcome in cardiac surgery. In this study, we look at the impact of evidence-based protocols implemented at Stanford Hospital.…”
  5. 1185

    Propensity-score matched CABG/Valve group. by Tomi Obafemi (12328433)

    Published 2023
    “…<div><p>Introduction</p><p>Adequate peri-operative care is essential to ensuring a satisfactory outcome in cardiac surgery. In this study, we look at the impact of evidence-based protocols implemented at Stanford Hospital.…”
  6. 1186
  7. 1187

    Robust Operation of Mesoporous Antireflective Coatings under Variable Ambient Conditions by Barry Reid (1559488)

    Published 2018
    “…In this work, we examine the effect of relative humidity on mesoporous ARCs and present a simple method for the preparation of ARCs with robust operation under variable conditions. …”
  8. 1188
  9. 1189
  10. 1190
  11. 1191
  12. 1192
  13. 1193
  14. 1194
  15. 1195
  16. 1196
  17. 1197

    Activation of Wnt/β-catenin signaling decreases mRNA expressions of <i>Scx</i>, <i>Mkx</i> and <i>Tnmd</i> in rat TDCs. by Yasuzumi Kishimoto (4282138)

    Published 2017
    “…<p>Relative expressions of <i>Axin2</i>, <i>Scx</i>, <i>Mkx</i>, and <i>Tnmd</i> in TDCs treated with 50 ng/ml Wnt3a with or without 5 μM IWR (an inhibitor of β-catenin) <b>(A)</b>, 0 to 4 μM BIO (an activator of β-catenin) <b>(B)</b>, or 0 to 20 μM IWR <b>(C)</b> for 72 hrs. …”
  18. 1198
  19. 1199
  20. 1200

    Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space by Charles E. Greif (21728091)

    Published 2025
    “…The complexes demonstrated submicromolar cytotoxic activity against human breast cancer cells MDA-MB-231 or MDA-MB-468 with IC<sub>50</sub>’s in the range of 0.4–5.0 μM. Complex <b>2e</b> shows high potency in vitro and decreases 3D-breast cancer mammosphere viability. …”